Author/Authors :
Liu, P Department of Oncology - Qingdao Hiser Medical Group - Qingdao, China , Wang, S Department of Oncology - Qingdao Hiser Medical Group - Qingdao, China , Fang, X Qingdao Institute for Food and Drug Control - Qingdao, China , Gao, Z.D Department of Oncology - Qingdao Hiser Medical Group - Qingdao, China , Shao, W Department of Oncology - Qingdao Hiser Medical Group - Qingdao, China , Long, L Department of Oncology - Qingdao Hiser Medical Group - Qingdao, China , Zhang, Y.C Department of Traumatic Orthopedics - Qingdao Hiser Medical Group, Qingdao, China
Abstract :
Background: Radiation pneumonitis (RP) is a common complication of thoracic radiation which affects patients’ ability to breathe, limits the deliverable intensity of radiotherapy and impairs clinical outcomes, indicating the need for timely diagnosis and management. The purpose of this study
was to determine the predictive capability of two peripheral inflammatory
cells for RP. Materials and Methods: A murine RP model was established
using SD rats that received a single dose of 20 Gy thoracic radiation. At 2 and
4 weeks post-radiation, mice were processed to harvest lungs for hematoxylin
-eosin (HE) staining and collect blood for flow cytometry analysis. Results: By
2 weeks post-radiation, histopathological changes had occurred in the lungs
indicating the onset of RP. Peripheral CD45+HIS48+ granulocytes were
significantly increased by the radiation treatment at both the early and later
time points (P<0.05). However, we did not observe a statistically significant
increase of CD45+CD11b/c+HIS48- monocytes/macrophages. Conclusion: Our
study highlights the possibility that increased levels of peripheral CD45+HIS48+
granulocytes could serve as a predictive indicator of RP. Early detection
provides the opportunity for early intervention and therefore, a reduction in the rate and extent of RP.
Keywords :
Radiation pneumonitis , granulocytes , monocytes/macrophages , peripheral , prediction